The MD blues: under-recognized depression and anxiety in medical trainees OY Mousa, MS Dhamoon, S Lander, AS Dhamoon PloS one 11 (6), e0156554, 2016 | 70 | 2016 |
Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995-2014 SO Antwi, OY Mousa, T Patel Annals of hepatology 17 (2), 274-285, 2018 | 29 | 2018 |
Hyperammonemia-induced encephalopathy: A rare devastating complication of bariatric surgery ML Kromas, OY Mousa, S John World journal of hepatology 7 (7), 1007, 2015 | 23 | 2015 |
Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study DM Chascsa, OY Mousa, S Pungpapong, N Zhang, A Chervenak, ... American Journal of Transplantation 18 (10), 2559-2565, 2018 | 16 | 2018 |
Chronic hepatitis C therapy in liver cirrhosis complicated by telaprevir-induced DRESS O Mousa, R Khalaf, RL Shannon, CI Egwim, SA Zela, V Ankoma-Sey Case reports in medicine 2014, 2014 | 10 | 2014 |
Impact of periampullary diverticulum on ERCP performance: a matched case-control study JE Corral, OY Mousa, PT Kröner, V Gomez, FJ Lukens Clinical endoscopy 52 (1), 65, 2019 | 8 | 2019 |
An argument for Vitamin D, A, and zinc monitoring in cirrhosis AH Koop, OY Mousa, LE Pham, JE Corral-Hurtado, S Pungpapong, ... Annals of hepatology 17 (6), 920-932, 2018 | 8 | 2018 |
Evolving role of liver transplantation in elderly recipients OY Mousa, JH Nguyen, Y Ma, B Rawal, KR Musto, MK Dougherty, ... Liver Transplantation 25 (9), 1363-1374, 2019 | 7 | 2019 |
Association between smoking and risk of primary sclerosing cholangitis: A systematic review and meta-analysis K Wijarnpreecha, P Panjawatanan, OY Mousa, W Cheungpasitporn, ... United European gastroenterology journal 6 (4), 500-508, 2018 | 6 | 2018 |
Acute On Chronic Liver Failure NJ Shah, OY Mousa, K Syed, S John StatPearls [Internet], 2020 | 5 | 2020 |
Unique phenotypic characteristics and clinical course in patients with ulcerative colitis and primary sclerosing cholangitis: a multicenter US experience MH Wang, OY Mousa, JJ Friton, LE Raffals, JA Leighton, SF Pasha, ... Inflammatory bowel diseases 26 (5), 774-779, 2020 | 5 | 2020 |
Volumetric laser endomicroscopy in the biliary and pancreatic ducts: a feasibility study with histological correlation JE Corral, OY Mousa, M Krishna, IJM Levink, KR Pursell, M Afsh, ... Endoscopy 50 (11), 1089-1094, 2018 | 5 | 2018 |
Crack lung: cocaine-induced lung injury R Shah, A Patel, O Mousa, D Manocha QJM: An International Journal of Medicine 108 (9), 749-749, 2015 | 5 | 2015 |
Heavy coffee consumption and risk of pancreatitis: a systematic review and meta-analysis K Wijarnpreecha, P Panjawatanan, OY Mousa, W Cheungpasitporn, ... Digestive diseases and sciences 63 (11), 3134-3140, 2018 | 4 | 2018 |
Impact of Direct Acting Antiviral (DAA) for HCV Treatment on Liver Transplant Outcomes: A Multicenter 15-year Experience. OY Mousa, NL Latt, BA Aqel, MD Leise, AP Keaveny, S Pungpapong Hepatology 66, 897A-897A, 2017 | 4 | 2017 |
Efficacy, tolerability and discontinuations of the current direct acting agents in chronic hepatitis C patients with cirrhosis O Mousa, LE Pham, CI Egwim, SA Zela, V Ankoma-Sey Hepatology 56, 1049A-1049A, 2012 | 4 | 2012 |
Clinical and endoscopic manifestations of gastrointestinal amyloidosis: a case series AH Koop, OY Mousa, MH Wang Clujul Medical 91 (4), 469, 2018 | 3 | 2018 |
A hybrid endoscopic technique to close tracheoesophageal fistula M Pang, O Mousa, M Werlang, B Brahmbhatt, T Woodward VideoGIE 3 (1), 15-16, 2018 | 3 | 2018 |
The era of first direct-acting antiviral agents: What did we learn? VASMD Omar Y. Mousa M.D., Surakit Pungpapong M.D. Clinical Liver Disease 8 (3), 72–75, 2016 | 3* | 2016 |
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities F Idalsoaga, AV Kulkarni, OY Mousa, M Arrese, JP Arab Frontiers in Medicine 7, 2020 | 2 | 2020 |